Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Managing patients with a preoperative diagnosis of AJCC/UICC stage I (T1N0M0) papillary thyroid carcinoma: East versus West, whose policy is best?

Literature DB >> 20162281

Managing patients with a preoperative diagnosis of AJCC/UICC stage I (T1N0M0) papillary thyroid carcinoma: East versus West, whose policy is best?

Ian D Hay¹.

Abstract

Entities: Disease Species

Mesh：

Year: 2010 PMID： 20162281 DOI： 10.1007/s00268-010-0469-5

Source DB: PubMed Journal: World J Surg ISSN： 0364-2313 Impact factor: 3.352

× No keyword cloud information.

14 in total

1. European consensus for the management of patients with differentiated thyroid carcinoma of the follicular epithelium.

Authors: Furio Pacini; Martin Schlumberger; Henning Dralle; Rossella Elisei; Johannes W A Smit; Wilmar Wiersinga
Journal: Eur J Endocrinol Date: 2006-06 Impact factor: 6.664

2. A vision for the surgical management of papillary thyroid carcinoma: extensive lymph node compartmental dissections and selective use of radioiodine.

Authors: Ernest L Mazzaferri
Journal: J Clin Endocrinol Metab Date: 2009-04 Impact factor: 5.958

Review 3. The pros and cons of prophylactic central compartment lymph node dissection for papillary thyroid carcinoma.

Authors: Ernest L Mazzaferri; Gerard M Doherty; David L Steward
Journal: Thyroid Date: 2009-07 Impact factor: 6.568

4. Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer.

Authors: David S Cooper; Gerard M Doherty; Bryan R Haugen; Bryan R Hauger; Richard T Kloos; Stephanie L Lee; Susan J Mandel; Ernest L Mazzaferri; Bryan McIver; Furio Pacini; Martin Schlumberger; Steven I Sherman; David L Steward; R Michael Tuttle
Journal: Thyroid Date: 2009-11 Impact factor: 6.568

5. Value of preoperative ultrasonography in the surgical management of initial and reoperative papillary thyroid cancer.

Authors: John M Stulak; Clive S Grant; David R Farley; Geoffrey B Thompson; Jon A van Heerden; Ian D Hay; Carl C Reading; J William Charboneau
Journal: Arch Surg Date: 2006-05

6. Papillary microcarcinoma of the thyroid: how should it be treated?

Authors: Yasuhiro Ito; Chisato Tomoda; Takashi Uruno; Yuuki Takamura; Akihiro Miya; Kaoru Kobayashi; Fumio Matsuzuka; Kanji Kuma; Akira Miyauchi
Journal: World J Surg Date: 2004-11 Impact factor: 3.352

7. Risks and adequacy of an optimized surgical approach to the primary surgical management of papillary thyroid carcinoma treated during 1999-2006.

Authors: Clive S Grant; John M Stulak; Geoffrey B Thompson; Melanie L Richards; Carl C Reading; Ian D Hay
Journal: World J Surg Date: 2010-06 Impact factor: 3.352

Review 8. Appropriate treatment for asymptomatic papillary microcarcinoma of the thyroid.

Authors: Yasuhiro Ito; Akira Miyauchi
Journal: Expert Opin Pharmacother Date: 2007-12 Impact factor: 3.889

9. Prophylactic lymph node dissection for papillary thyroid cancer less than 2 cm: implications for radioiodine treatment.

Authors: Stéphane Bonnet; Dana Hartl; Sophie Leboulleux; Eric Baudin; Jean D Lumbroso; Abir Al Ghuzlan; Linda Chami; Martin Schlumberger; Jean Paul Travagli
Journal: J Clin Endocrinol Metab Date: 2008-12-30 Impact factor: 5.958

10. Excellent prognosis of patients with solitary T1N0M0 papillary thyroid carcinoma who underwent thyroidectomy and elective lymph node dissection without radioiodine therapy.

Authors: Yasuhiro Ito; Hiroo Masuoka; Mitsuhiro Fukushima; Hiroyuki Inoue; Minoru Kihara; Chisato Tomoda; Takuya Higashiyama; Yuuki Takamura; Kaoru Kobayashi; Akihiro Miya; Akira Miyauchi
Journal: World J Surg Date: 2010-06 Impact factor: 3.352

5 in total

Managing patients with a preoperative diagnosis of AJCC/UICC stage I (T1N0M0) papillary thyroid carcinoma: East versus West, whose policy is best?

1. European consensus for the management of patients with differentiated thyroid carcinoma of the follicular epithelium.

2. A vision for the surgical management of papillary thyroid carcinoma: extensive lymph node compartmental dissections and selective use of radioiodine.

Review 3. The pros and cons of prophylactic central compartment lymph node dissection for papillary thyroid carcinoma.

4. Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer.

5. Value of preoperative ultrasonography in the surgical management of initial and reoperative papillary thyroid cancer.

6. Papillary microcarcinoma of the thyroid: how should it be treated?

7. Risks and adequacy of an optimized surgical approach to the primary surgical management of papillary thyroid carcinoma treated during 1999-2006.

Review 8. Appropriate treatment for asymptomatic papillary microcarcinoma of the thyroid.

9. Prophylactic lymph node dissection for papillary thyroid cancer less than 2 cm: implications for radioiodine treatment.

10. Excellent prognosis of patients with solitary T1N0M0 papillary thyroid carcinoma who underwent thyroidectomy and elective lymph node dissection without radioiodine therapy.

1. The role of clinicians in determining radioactive iodine use for low-risk thyroid cancer.

2. Use of radioactive iodine for thyroid cancer.

3. Surgeon training and use of radioactive iodine in stage I thyroid cancer patients.

4. Variation in the management of thyroid cancer.

5. The relationship between extent of thyroid cancer surgery and use of radioactive iodine.